Observational studyMedicine2025

Nutritional Risk Index (NRI) predicts the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors (PD-1/PD-L1).

Yuehua Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.